Belatacept conversion in an HIV-positive kidney transplant recipient following anti-thymocyte globulin induction. (Q47708589)

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:28708266%20AND%20SRC:MED&resulttype=core&format=json

25 March 2020

title

Belatacept conversion in an HIV-positive kidney transplant recipient following anti-thymocyte globulin induction (English)

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:28708266%20AND%20SRC:MED&resulttype=core&format=json

25 March 2020

0 references

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:28708266%20AND%20SRC:MED&resulttype=core&format=json

25 March 2020

Samir J Patel

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:28708266%20AND%20SRC:MED&resulttype=core&format=json

25 March 2020

Ashvin Baru

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:28708266%20AND%20SRC:MED&resulttype=core&format=json

25 March 2020

A Osama Gaber

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:28708266%20AND%20SRC:MED&resulttype=core&format=json

25 March 2020

Rustin D Crutchley

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:28708266%20AND%20SRC:MED&resulttype=core&format=json

25 March 2020

Venkataraman Ramanathan

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:28708266%20AND%20SRC:MED&resulttype=core&format=json

25 March 2020

Richard J Knight

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:28708266%20AND%20SRC:MED&resulttype=core&format=json

25 March 2020

publication date

11 September 2017

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:28708266%20AND%20SRC:MED&resulttype=core&format=json

Transplant Infectious Disease

25 March 2020

published in

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:28708266%20AND%20SRC:MED&resulttype=core&format=json

25 March 2020

volume

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:28708266%20AND%20SRC:MED&resulttype=core&format=json

25 March 2020

issue

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:28708266%20AND%20SRC:MED&resulttype=core&format=json

Drug-drug interactions between antiretroviral and immunosuppressive agents in HIV-infected patients after solid organ transplantation: a review

25 March 2020

cites work

1 reference

Pharmacologic issues of antiretroviral agents and immunosuppressive regimens in HIV-infected solid organ transplant recipients

21 January 2018

1 reference

Combination Drug Products for HIV-A Word of Caution for the Transplant Clinician.

21 January 2018

1 reference

A phase III study of belatacept-based immunosuppression regimens versus cyclosporine in renal transplant recipients (BENEFIT study).

21 January 2018

1 reference

Long-term belatacept exposure maintains efficacy and safety at 5 years: results from the long-term extension of the BENEFIT study

21 January 2018

1 reference

Switching from calcineurin inhibitor-based regimens to a belatacept-based regimen in renal transplant recipients: a randomized phase II study

21 January 2018

1 reference

De Novo Belatacept in a Human Immunodeficiency Virus-Positive Kidney Transplant Recipient.

21 January 2018

1 reference

Belatacept Conversion in an HIV-Positive Kidney Transplant Recipient With Prolonged Delayed Graft Function

21 January 2018

1 reference

Integrase strand transferase inhibitors: the preferred antiretroviral regimen in HIV-positive renal transplantation

21 January 2018

1 reference

Outcomes of Kidney Transplantation in HIV-Infected Recipients

21 January 2018

1 reference

Thymoglobulin-associated Cd4+ T-cell depletion and infection risk in HIV-infected renal transplant recipients

21 January 2018

1 reference

Immunosuppression regimen and the risk of acute rejection in HIV-infected kidney transplant recipients

21 January 2018

1 reference

Induction Immunosuppression and Clinical Outcomes in Kidney Transplant Recipients Infected With Human Immunodeficiency Virus.

21 January 2018

1 reference

Immunosuppressant pharmacokinetics and dosing modifications in HIV-1 infected liver and kidney transplant recipients.

21 January 2018

1 reference

Belatacept and Long-Term Outcomes in Kidney Transplantation

21 January 2018

1 reference

CTLA-4 upregulation during HIV infection: association with anergy and possible target for therapeutic intervention

21 January 2018

1 reference

Upregulation of CTLA-4 by HIV-specific CD4+ T cells correlates with disease progression and defines a reversible immune dysfunction

21 January 2018

1 reference

Costimulation blockade alters germinal center responses and prevents antibody-mediated rejection

21 January 2018

1 reference

21 January 2018

Identifiers

DOI

10.1111/TID.12748

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:28708266%20AND%20SRC:MED&resulttype=core&format=json

25 March 2020

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:28708266%20AND%20SRC:MED&resulttype=core&format=json